Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, feeling hungry on day three of Mounjaro is completely normal. At 2.5 mg, the starter dose is designed to help your body adjust to tirzepatide, not to suppress appetite in any dramatic way — most people notice little change in hunger during the first week. The appetite effects typically build over several weeks as your dose increases, so day three is genuinely too early to judge. These are prescription-only medicines assessed and dispensed under clinical supervision; how your treatment progresses is a conversation with your prescriber, not something to tweak alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: you injected on Monday morning, you've been careful with your meals, and by Wednesday you're just as hungry as you were before you started. You might be wondering whether the pen was faulty, whether you did it wrong, or whether Mounjaro simply isn't going to work for you. None of those things are likely to be true.
The first pen contains 2.5 mg of tirzepatide per dose. That dose exists to give your digestive system a chance to get used to the medicine, nausea and other gastrointestinal effects are most noticeable when you start or increase, so the titration schedule is deliberately cautious. The NHS tirzepatide medicines page describes this clearly: the appetite-related effects become more pronounced as the dose increases over weeks and months. Day three at the starting dose is simply too early for the pharmacology to have meaningfully shifted your hunger signals.
Tirzepatide works by activating both GIP and GLP-1 receptors, pathways involved in slowing gastric emptying, increasing feelings of fullness, and regulating appetite. That mechanism takes time to produce noticeable changes at each dose level. Think of it less like flicking a switch and more like gradually turning a dial. By weeks four to eight, most people on Mounjaro begin to notice their appetite behaving differently. Some feel it sooner; a few don't feel it until they reach a higher maintenance dose. Both are within the range of normal clinical experience.
Because appetite suppression hasn't kicked in yet, what you choose to put on your plate in week one carries real weight. This is one of the things that catches people out: they expect the medicine to do the work immediately and eat as usual, then feel discouraged when hunger persists. The two work together, not sequentially.
Protein is worth prioritising. It's the most satiating macronutrient, and on days when tirzepatide isn't yet doing much, a breakfast with decent protein content will keep you full longer than toast alone. Eating slowly also helps, tirzepatide slows gastric emptying over time, but eating quickly bypasses that signal even when the medicine is fully active. Plenty of water matters too, because thirst and hunger are easy to confuse, particularly in the first week when you're paying close attention to every sensation. For practical guidance on what tends to work well alongside treatment, our page on eating well on Mounjaro goes into considerably more detail.
Avoid the temptation to reduce calories sharply right now. You're three days in, you're still hungry, and a steep deficit on top of that will just make you miserable. A modest, sustainable reduction alongside a protein-forward approach is the sensible starting point, and your prescriber can advise further if you'd like a more structured plan.
Most people who follow the titration schedule find that hunger decreases meaningfully by week four to eight, and continues to reduce with each dose step. A smaller number find that even at higher doses, appetite suppression is milder than they hoped. That's a legitimate clinical conversation, not a personal failure.
There are a few patterns worth flagging to your prescriber. If you're at a maintenance dose and still experiencing hunger that's making the programme feel unworkable, that's worth discussing before assuming the medicine isn't right for you. If you're finding that hunger spikes sharply in the days before your next weekly injection (a pattern sometimes called the "wear-off" effect), again, your prescriber is the right person to talk to, it can sometimes be addressed through timing or dose.
The broader guide to hunger on Mounjaro covers these patterns across the full treatment course. And if you're finding that day four or five brings a different experience to day three, our page on what tends to happen after day three picks up from exactly this point. Some people also experience the opposite trajectory, if appetite disappears more than feels comfortable, that has its own explanation too.
Hunger on day three isn't a medical concern. But there are things that are. Severe, persistent stomach pain (particularly if it radiates to your back) needs same-day medical attention. Vomiting that stops you keeping fluids down, signs of dehydration, or anything else that genuinely worries you: contact a healthcare professional. The MHRA's Yellow Card scheme exists for reporting suspected side effects, and your prescriber wants to know if something doesn't feel right.
For everything that falls short of an emergency, aftercare matters. People starting Mounjaro sometimes find day one passes without any appetite change at all, which is entirely normal, and it can help to know what others experience on day two, when hunger is equally common. Having a prescriber you can actually reach makes a real difference. You can read about how our clinical team approaches ongoing support on the clinical team page, and our FAQs cover many of the first-week questions we hear most often.
If you're still in the research phase, comparing options, or wondering how to get started through a regulated service, you can explore our weight-loss treatments and start a free consultation whenever you're ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.